Cytokine signaling pathway involved in wound healing and inflammation modulation

This entry refers to a broad class of pathways rather than a single, specific molecule or receptor. It encompasses multiple cytokines, their receptors, and downstream signaling components. For structured data purposes, it is too general; more precise targets would be individual cytokines (e.g., Interleukin-1 receptor), their receptors (e.g., IL-1R), or key pathway nodes (e.g., Janus kinase 1). Cytokine signaling pathways involved in wound healing and inflammation modulation represent an intricate network that orchestrates the body’s response to injury. Cytokines are soluble proteins secreted primarily by immune cells that act as chemical messengers coordinating cellular activities during all phases of wound repair—hemostasis, inflammation, proliferation, and remodeling.[3] Key pro-inflammatory cytokines such as interleukin‑1 (IL‑1), interleukin‑6 (IL‑6), tumor necrosis factor-alpha (TNF-alpha), and interleukin‑8 (IL‑8) initiate leukocyte recruitment and pathogen clearance during early stages.[3] Anti-inflammatory mediators including transforming growth factor-beta (TGF-beta), interleukin‑4 (IL‑4), IL–13 help resolve inflammation while promoting fibroblast proliferation and extracellular matrix deposition necessary for tissue regeneration.[3][7] These processes are regulated through canonical intracellular cascades—primarily the JAK/STAT, PI3K/Akt/mTOR,[6] MAPK,[3] NF-kB,[5], among others—which transmit signals from cell surface receptors into changes in gene expression controlling cell survival/apoptosis balance,[2] migration/proliferation rates,[9], angiogenesis,[7], collagen synthesis,[7], etc. Dysregulation at any point can result in pathological outcomes: excessive/prolonged pro-inflammatory activity leads to chronic non-healing wounds seen especially in diabetes mellitus patients; conversely overactive anti-inflammation may cause fibrosis/scarring.[5][7] Therapeutic strategies have focused on modulating these networks using biologics that block individual cytokines/receptors or small molecules inhibiting key kinases like JAKs. However due to redundancy/pleiotropy within the system—and its central role maintaining host defense—such interventions carry risks including heightened susceptibility to infections.[8] In summary: “cytokine signaling pathways involved in wound healing/inflammation modulation” describes an essential but highly complex set of molecular interactions rather than a discrete druggable target. For clinical translation or database structuring purposes it should be broken down into its constituent molecules/receptors/pathways for specificity.

Other names

Cytokine-mediated signaling in wound healingInflammatory cytokine pathwaysWound healing cytokine networksPro-inflammatory/anti-inflammatory cytokine pathways

Drugs targeting these pathways act by one or more of the following mechanisms: - Blocking pro-inflammatory cytokines or their receptors to reduce inflammation and promote tissue repair[8][5] - Modulating anti-inflammatory signals to enhance resolution of inflammation and support regeneration[7][3] - Inhibiting intracellular kinases like JAKs to prevent downstream inflammatory gene expression